Lv1
90 积分 2026-01-15 加入
Lactate‐Depleting Engineered Probiotics Remodel the Tumor Microenvironment and Enhance PD‐1 Blockade
16天前
已完结
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy in preclinical mouse models
30天前
已完结
Engineering bacteria as interactive cancer therapies
2个月前
已完结
FAP-Targeted LTBR Agonist Drives HEV Differentiation and Immune Niche Formation for Improved Immunotherapy Response in Solid Tumours
3个月前
已完结
Neoadjuvant stereotactic body radiation therapy plus immune therapy favorably remodels the hepatocellular carcinoma tumor microenvironment
3个月前
已完结
Programmable bacteria synergize with PD-1 blockade to overcome cancer cell–intrinsic immune resistance mechanisms
3个月前
已完结
Metabolic challenges and interventions in CAR T cell therapy
6个月前
已完结
Target antigen–displaying extracellular vesicles boost CAR T cell efficacy in cell and mouse models of neuroblastoma
7个月前
已完结
皖公网安备34019202002308
